CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP

PRODUCT MONOGRAPH

CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP

Chlorhexidine Gluconate 0.12% Oral Rinse Liquid, 0.12% Chlorhexidine Gluconate Antigingivital Oral Rinse

Sage Product LLC 3909 Three Oaks Road Cary, IL 60013 USA

Submission Control No: 180308

Date of Preparation: February 17, 2015

Page 1 of 19

Table of Contents

PART I: HEALTH PROFESSIONAL INFORMATION.........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS ...................................................................................................3 WARNINGS AND PRECAUTIONS..................................................................................4 ADVERSE REACTIONS....................................................................................................6 DOSAGE AND ADMINISTRATION ................................................................................6 OVERDOSAGE ..................................................................................................................7 ACTION AND CLINICAL PHARMACOLOGY ..............................................................8 STORAGE AND STABILITY............................................................................................9 SPECIAL HANDLING INSTRUCTIONS .........................................................................9 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................10

PART II: SCIENTIFIC INFORMATION ...............................................................................11 PHARMACEUTICAL INFORMATION..........................................................................11 CLINICAL TRIALS ..........................................................................................................12 DETAILED PHARMACOLOGY .....................................................................................13 MICROBIOLOGY ............................................................................................................13 TOXICOLOGY .................................................................................................................14 REFERENCES ..................................................................................................................15

PART III: PATIENT MEDICATION INFORMATION ........................................................16

Page 2 of 19

CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP chlorhexidine gluconate 0.12% oral rinse

PART I: HEALTH PROFESSIONAL INFORMATION

SUMMARY PRODUCT INFORMATION

Route of Administration

Oral

Dosage Form / Strength

Liquid/0.12% w/w

All Nonmedicinal Ingredients

Alcohol, FD&C Blue # 1, flavour, glycerine, PEG 40-sorbitan diisostearate, saccharin sodium and USP Purified water.

INDICATIONS AND CLINICAL USE

Chlorhexidine gluconate 0.12% oral rinse is indicated for use as part of a professional program for the treatment of moderate to severe gingivitis, and for the management of associated gingival bleeding and inflammation between dental visits. For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS

Geriatrics (> 65 years of age):

No data is available

Pediatrics (< 18 years of age):

Since the safety and efficacy of chlorhexidine gluconate oral rinse has not yet been fully established, the benefits of its use should be weighed against the possible risks.

CONTRAINDICATIONS

Chlorhexidine gluconate 0.12 % oral rinse should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.

Page 3 of 19

WARNINGS AND PRECAUTIONS

General

1. For patients having coexisting gingivitis and periodontitis, the absence of gingival inflammation following treatment with chlorhexidine gluconate oral rinse may not be indicative of the absence of underlying periodontitis. Appropriate treatment of periodontitis is therefore indicated.

2. Chlorhexidine gluconate oral rinse may cause staining of oral surfaces such as the film on tooth surfaces, restorations, and the dorsum of the tongue. Stain will be more pronounced in patients who have heavier accumulations of un-removed plaque. Stain resulting from use of chlorhexidine gluconate oral rinse does not adversely affect the health of gingivae or other oral tissue. Stain can be removed from most tooth surfaces by conventional professional prophylactic techniques. Additional time may be required to complete the prophylaxis. Discretion should be used when treating patients with exposed root surfaces or anterior facial restorations with rough surfaces or margins. If natural stains cannot be removed from these surfaces by a dental prophylaxis, patients should be excluded from chlorhexidine gluconate oral rinse treatment if the risk of permanent discolouration is unacceptable. Stains in these areas may be difficult to remove by dental prophylaxis and on rare occasions may necessitate replacement of these restorations.

3. A few patients may experience an alteration in taste perception while undergoing treatment with chlorhexidine gluconate oral rinse. Most of these patients accommodate to this effect with continued use of chlorhexidine gluconate oral rinse. Rare instances of permanent taste alteration following chlorhexidine gluconate oral rinse use have been reported via post-marketing product surveillance.

4. For maximum effectiveness the patient should avoid rinsing their mouth (with water or other mouthwashes), brushing their teeth, eating or drinking for about 30 minutes after using chlorhexidine gluconate oral rinse.

Carcinogenesis and Mutagenesis

No evidence of carcinogenicity was reported in two rat studies in which chlorhexidine was administered in their drinking water. The studies were two years in duration and delivered chlorhexidine at dose levels of up to 200 mg/kg/day.

No evidence of mutagenicity was observed when chlorhexidine gluconate was evaluated by the dominant lethal assay in mice and micronucleus assay in hamsters. Mutagenicity studies, using bacterial cell system, with or without metabolic activation, produced contradictory results, which are unexpected with drugs having antibacterial activity. While Suessmuth et al. (1979) and Ackerman-Schmidt et al. (1982) obtained positive results, Evans et al. (1978) and Sakagami et

Page 4 of 19

al. (1988) found no evidence of genotoxicity for chlorhexidine. The clinical significance of these results is unclear Special Populations Pregnant Women: Reproduction and fertility studies with chlorhexidine gluconate have been conducted. No evidence of impaired fertility was observed in male and female rats at doses up to 100 mg/kg/day, and no evidence of harm to the fetus was observed in rats and rabbits at doses up to 300 mg/kg/day and 40 mg/kg/day, respectively. These doses are approximately 100, 300, and 40 times that which would result from a person ingesting 30 mL (2 capfuls) of chlorhexidine gluconate 0.12% oral rinse per day. Since controlled studies in pregnant women have not been conducted, the benefits of use of the drug in pregnant women should be weighed against possible risk to the fetus. Nursing Women: It is unknown whether this drug is excreted in human milk. In parturition and lactation studies with rats, no evidence of impaired parturition or of toxic effects to suckling pups was observed when chlorhexidine gluconate was administered to dams at doses that were over 100 times greater than the dose which would result if a person ingested the entire recommended dose of chlorhexidine gluconate 0.12% oral rinse on a daily basis. Pediatrics (< 18 years of age): Since the safety and efficacy of chlorhexidine gluconate oral rinse has not yet been fully established, the benefits of its use should be weighed against the possible risks. Geriatrics (> 65 years of age): No data is available

Page 5 of 19

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download